Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Matinas BioPharma Holdings, Inc. MTNB

Set alert

Price alert · MTNB

All alert types
1.51 USD -0.39 -20.53%

At close · Oct 30

1.42 -0.09 -5.96%

After hours · Oct 30, 6:52 PM ET

Bid
1.49 × 700
Ask
1.68 × 100
1.51 Day range 1.91
0.585 52-week range 13.08
YTD
+157.68%
1 year
+11.03%
Open
1.87
Prev close
1.90
Mkt cap
1.48M
Vol
83.00K
Avg vol
92.27K
EPS
-17.55
P/E
0.00
Div yield
0.00%
More statistics
Low
1.51
High
1.91
Forward P/E
-0.17
Beta
1.73
Short ratio
0.19
Inst. own
26.08%
Dividend
0.00
Ex-div date
50-d avg
1.38
200-d avg
6.37
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for MTNB has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-94.31 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-3 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 3

Valuation

P/E -0.3×
FY 2016: -10.6×FY 2017: -6.8×FY 2018: -4.1×FY 2019: -21.1×FY 2020: -13.0×FY 2021: -10.0×FY 2022: -8.3×FY 2023: -2.0×FY 2024: -0.1×FY 2025: -0.3×
FY 2016 5y median -2.0× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 701×FY 2018: 487×FY 2019: 3670×FY 2020: 1691×FY 2021: 6433×FY 2022: 34.0×FY 2023: 42.9×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 34.0× FY 2025
P/B 0.7×
FY 2016: 11.3×FY 2017: 9.8×FY 2018: 3.6×FY 2019: 10.0×FY 2020: 4.2×FY 2021: 4.0×FY 2022: 3.0×FY 2023: 2.4×FY 2024: 0.3×FY 2025: 0.7×
FY 2016 5y median 2.4× FY 2025
P/FCF -0.5×
FY 2016: -13.2×FY 2017: -8.5×FY 2018: -5.4×FY 2019: -22.7×FY 2020: -15.4×FY 2021: -13.7×FY 2022: -5.4×FY 2023: -3.0×FY 2024: -0.2×FY 2025: -0.5×
FY 2016 5y median -3.0× FY 2025
EV/EBITDA -0.1×
FY 2016: -9.4×FY 2017: -6.0×FY 2018: -3.2×FY 2019: -17.2×FY 2020: -11.1×FY 2021: -8.7×FY 2022: -5.3×FY 2023: -2.1×FY 2024: 0.1×FY 2025: -0.1×
FY 2016 5y median -2.1× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 654×FY 2018: 387×FY 2019: 3470×FY 2020: 1636×FY 2021: 5938×FY 2022: 33.1×FY 2023: 41.7×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 33.1× FY 2025
FCF Yield -218.6%
FY 2016: -7.6%FY 2017: -11.8%FY 2018: -18.6%FY 2019: -4.4%FY 2020: -6.5%FY 2021: -7.3%FY 2022: -18.5%FY 2023: -33.0%FY 2024: -640.1%FY 2025: -218.6%
FY 2016 5y median -33.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: -5919.6%FY 2018: -5568.0%FY 2019: -12409.0%FY 2020: -8968.8%FY 2021: -44090.9%FY 2022: -423.1%FY 2023: 14.1%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: -11024.6%FY 2018: -12230.9%FY 2019: -21067.4%FY 2020: -15288.4%FY 2021: -74954.5%FY 2022: -771.3%FY 2023: -2168.4%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median -771.3% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: -10345.9%FY 2018: -11760.4%FY 2019: -19343.4%FY 2020: -14177.0%FY 2021: -70554.5%FY 2022: -658.6%FY 2023: -2093.2%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median -658.6% FY 2025
ROE -214.2%
FY 2016: -106.3%FY 2017: -145.0%FY 2018: -87.2%FY 2019: -52.6%FY 2020: -35.2%FY 2021: -44.4%FY 2022: -57.3%FY 2023: -119.2%FY 2024: -319.5%FY 2025: -214.2%
FY 2016 5y median -119.2% FY 2025
ROIC -108.1%
FY 2016: -97.1%FY 2017: -130.1%FY 2018: -81.3%FY 2019: -50.3%FY 2020: -35.7%FY 2021: -43.0%FY 2022: -32.7%FY 2023: -102.7%FY 2024: -187.1%FY 2025: -108.1%
FY 2016 5y median -102.7% FY 2025
ROA -143.5%
FY 2016: -77.4%FY 2017: -107.4%FY 2018: -70.6%FY 2019: -43.2%FY 2020: -31.6%FY 2021: -38.0%FY 2022: -26.6%FY 2023: -91.4%FY 2024: -191.8%FY 2025: -143.5%
FY 2016 5y median -91.4% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: -100.0%FY 2017: 0.0%FY 2018: -20.0%FY 2019: -25.0%FY 2020: 76.3%FY 2021: -79.2%FY 2022: 9560.6%FY 2023: -65.6%FY 2024: -100.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 65.5%
FY 2016: 16.7%FY 2017: -99.9%FY 2018: 11.2%FY 2019: -29.2%FY 2020: -27.9%FY 2021: -2.2%FY 2022: 0.6%FY 2023: 3.4%FY 2024: 15.2%FY 2025: 65.5%
FY 2016 FY 2025
EPS (diluted) 59.8%
FY 2016: 25.7%FY 2017: -29.9%FY 2018: 16.1%FY 2019: 25.2%FY 2020: 2.6%FY 2021: 3.6%FY 2022: 40.5%FY 2023: -76.0%FY 2024: 5.7%FY 2025: 59.8%
FY 2016 FY 2025
Free Cash Flow 55.9%
FY 2016: 22.5%FY 2017: -102.7%FY 2018: 12.5%FY 2019: -33.5%FY 2020: -19.8%FY 2021: 10.9%FY 2022: -29.5%FY 2023: 22.7%FY 2024: -2.5%FY 2025: 55.9%
FY 2016 FY 2025

Financial Health

Current Ratio 2.8×
FY 2016: 3.2×FY 2017: 3.6×FY 2018: 4.6×FY 2019: 9.7×FY 2020: 17.3×FY 2021: 11.7×FY 2022: 8.1×FY 2023: 5.9×FY 2024: 3.0×FY 2025: 2.8×
FY 2016 5y median 5.9× FY 2025
Quick Ratio 2.8×
FY 2016: 3.2×FY 2017: 3.6×FY 2018: 4.6×FY 2019: 9.7×FY 2020: 17.3×FY 2021: 11.7×FY 2022: 8.1×FY 2023: 5.9×FY 2024: 3.0×FY 2025: 2.8×
FY 2016 5y median 5.9× FY 2025
Debt / Equity 0.3×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.2×FY 2024: 0.4×FY 2025: 0.3×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA 0.3×
FY 2016: 0.5×FY 2017: 0.4×FY 2018: 0.8×FY 2019: 1.0×FY 2020: 0.4×FY 2021: 0.7×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.3×
FY 2016 5y median 0.2× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 5443.5%FY 2017: 579.6%FY 2018: 1005.9%FY 2019: 677.9%FY 2020: 255.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: -57822.9%FY 2017: -3928.2%FY 2018: -4169.1%FY 2019: -12861.8%FY 2020: -3041.9%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31